Cancer risk following organ transplantation: a nationwide cohort study in Sweden

British Journal of Cancer - Tập 89 Số 7 - Trang 1221-1227 - 2003
Johanna Adami1, H Gäbel2, B Lindelöf3, Karin M. Ekström4, B Rydh4, Bengt Glimelius5, Anders Ekbom4, Hans‐Olov Adami4, Fredrik Granath4
1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, SE-171 77, Stockholm, Sweden
2The Transplant Unit, National Board of Health and Welfare, Stockholm, Sweden 

3Department of Dermatology, Karolinska Hospital, Stockholm, Sweden
4#N# Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
5Department of Oncology, Radiology and Clinical Immunology, University Hospital, Uppsala

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307–314

Alloub MI, Barr BB, McLaren KM, Smith IW, Bunney MH, Smart GE (1989) Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 298: 153–156

Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JA (1989) Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1: 124–129

Birkeland SA, Lokkegaard H, Storm HH (2000) Cancer risk in patients on dialysis and after renal transplantation. Lancet 355: 1886–1887

Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L, et al (1995) Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 60: 183–189

Blohme I, Brynger H (1985) Malignant disease in renal transplant patients. Transplantation 39: 23–25

Bouwes Bavinck JN, Claas FH, Hardie DR, Green A, Vermeer BJ, Hardie IR (1997) Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 108: 708–711

Breslow NE, Day NE (1987) Statistical methods in cancer research. Volume 2 The design and analysis of cohort studies. IARC Sci Publ 1–406

Fairley CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG, Amiss N (1994) The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 41: 101–105

Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, Goldman S, Svensson C, Adami HO, Melbye M (1997) Sexually transmitted infection as a cause of anal cancer. N Engl J Med 337: 1350–1358

Galloway DA, Daling JR (1996) Is the evidence implicating human papillomavirus type 16 in esophageal cancer hard to swallow? J Natl Cancer Inst 88: 1421–1423

Goedert J (2000), In: Infectious Causes of Cancer. Targets For Intervention. Press H (ed). New Jersey

Gokal E (1988) Renal oestodystrophy and aluminium bone disease in CAPD patients. Clin Nephrol (Suppl 30): 64–67

Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC (1994) A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361–1392

Hoshida Y, Tsukuma H, Yasunaga Y, Xu N, Fujita MQ, Satoh T, Ichikawa Y, Kurihara K, Imanishi M, Matsuno T, Aozasa K (1997) Cancer risk after renal transplantation in Japan. Int J Cancer 71: 517–520

Hoover R, Fraumeni Jr JF (1973) Risk of cancer in renal-transplant recipients. Lancet 2: 5–7

Huang JQ, Sridhar S, Chen Y, Hunt RH (1998) Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114: 1169–1179

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol 64. Human Papillomaviruses. (1995) In Lyon: International Agency for Research on Cancer

Kantor AF, Hoover RN, Kinlen LJ, McMullan MR, Fraumenti Jr JF (1987) Cancer in patients receiving long-term dialysis treatment. Am J Epidemiol 126: 370–376

Kinlen LJ (1992) Immunosuppression and cancer. IARC Sci Publ 116: 237–253

Kinlen LJ, Sheil AG, Peto J, Doll R (1979) Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 2: 1461–1466

Kyllonen L, Salmela K, Pukkala E (2000) Cancer incidence in a kidney-transplanted population. Transpl Int 13(Suppl 1): S394–S398

Lagiou P, Kuper H, Stuver SO, Tzonou A, Trichopoulos D, Adami HO (2000) Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 92: 1096–1099

Lindelof B, Sigurgeirsson B, Gabel H, Stern RS (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143: 513–519

Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 354: 93–99

Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Moller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125–1131

Nilsson AC, Spetz CL, Carsjo K, Nightingale R, Smedby B (1994) Reliability of the hospital registry. The diagnostic data are better than their reputation. Lakartidningen 91: 598,603–605

Nyren O, McLaughlin JK, Gridley G, Ekbom A, Johnell O, Fraumeni Jr JF, Adami HO (1995) Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Natl Cancer Inst 87: 28–33

Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342: 1514–1516

Penn I (1991) The changing pattern of posttransplant malignancies. Transplant Proc 23: 1101–1103

Penn I (1993) Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 7: 431–445

Penn I (2000) Cancers in renal transplant recipients. Adv Ren Replace Ther 7: 147–156

Porreco R, Penn I, Droegemueller W, Greer B, Makowski E (1975) Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 45: 359–364

Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, Schreiber RD (2001) IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107–1111

Sillman F, Stanek A, Sedlis A, Rosenthal J, Lanks KW, Buchhagen D, Nicastri A, Boyce J (1984) The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol 150: 300–308

The Swedish Cancer Registry (2001) Cancer Incidence in Sweden, (1998) Stockholm: National Board of Health Welfare

The Swedish Registry of Uremic Care (2000) Publication no 7

Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA (2000) Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 11: 185–192

Ylitalo N, Sorensen P, Josefsson AM, Magnusson PK, Andersen PK, Ponten J, Adami HO, Gyllensten UB, Melbye M (2000) Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case–control study. Lancet 355: 2194–2198